1. Home
  2. AAPG
  3. AAPG News

Latest Ascentage Pharma Group International American Depository Shares (AAPG) News on October 5, 2025

3 Global Growth Companies With Insider Ownership Up To 31%
AAPG

Simply Wall St.

3 days ago

3 Global Growth Companies With Insider Ownership Up To 31%

Asian Growth Companies With High Insider Ownership October 2025
AAPG

Simply Wall St.

3 days ago

Asian Growth Companies With High Insider Ownership October 2025

3 Asian Growth Companies With Insider Ownership Expecting Up To 69% Earnings Growth
AAPG

Simply Wall St.

3 days ago

3 Asian Growth Companies With Insider Ownership Expecting Up To 69% Earnings Growth

Global Growth Stocks With Strong Insider Ownership
AAPG

Simply Wall St.

4 days ago

Global Growth Stocks With Strong Insider Ownership

Asian Growth Companies With High Insider Ownership In October 2025
AAPG

Simply Wall St.

4 days ago

Asian Growth Companies With High Insider Ownership In October 2025

Global's Top 3 Insider-Owned Growth Stocks To Watch
AAPG

Simply Wall St.

5 days ago

Global's Top 3 Insider-Owned Growth Stocks To Watch

Global Growth Companies With High Insider Ownership To Watch
AAPG

Simply Wall St.

13 days ago

Global Growth Companies With High Insider Ownership To Watch

Exploring High Growth Tech Stocks In Asia
AAPG

Simply Wall St.

3 months ago

Exploring High Growth Tech Stocks In Asia

Asian Growth Companies With Up To 33% Insider Ownership
AAPG

Simply Wall St.

3 months ago

Asian Growth Companies With Up To 33% Insider Ownership

AAPG

MT Newswires

4 months ago

Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
AAPG

GlobeNewswire

4 months ago

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress
AAPG

GlobeNewswire

4 months ago

Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress

Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
AAPG

GlobeNewswire

4 months ago

Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report

Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
AAPG

GlobeNewswire

4 months ago

Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors

Asian Growth Companies With High Insider Ownership In May 2025
AAPG

Simply Wall St.

4 months ago

Asian Growth Companies With High Insider Ownership In May 2025

High Growth Tech Stocks in Asia for May 2025
AAPG

Simply Wall St.

4 months ago

High Growth Tech Stocks in Asia for May 2025

Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025
AAPG

GlobeNewswire

4 months ago

Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025

Is Ascentage Pharma (AAPG) the Best Performing Healthcare Stock to Buy Now?
AAPG

Insider Monkey

5 months ago

Is Ascentage Pharma (AAPG) the Best Performing Healthcare Stock to Buy Now?

Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax
AAPG

GlobeNewswire

5 months ago

Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax

High Growth Tech Stocks in Asia to Watch This April 2025
AAPG

Simply Wall St.

5 months ago

High Growth Tech Stocks in Asia to Watch This April 2025

Asian Growth Companies With High Insider Ownership
AAPG

Simply Wall St.

5 months ago

Asian Growth Companies With High Insider Ownership

Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin
AAPG

GlobeNewswire

5 months ago

Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin

Ascentage Pharma Drugs Included in Chinese Society of Clinical Oncology Guidelines
AAPG

Exec Edge

5 months ago

Ascentage Pharma Drugs Included in Chinese Society of Clinical Oncology Guidelines

AAPG

MT Newswires

5 months ago

Ascentage Pharma Says 2 Investigational Drugs Added to 2025 CSCO Guidelines

Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines
AAPG

GlobeNewswire

5 months ago

Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines

Stocks To Watch In Gloomy Market — Including This Breakout IPO
AAPG

Investor's Business Daily

6 months ago

Stocks To Watch In Gloomy Market — Including This Breakout IPO

Asian Growth Stocks With Strong Insider Confidence
AAPG

Simply Wall St.

6 months ago

Asian Growth Stocks With Strong Insider Confidence

Exploring XD And Two Other High Growth Tech Stocks In Asia
AAPG

Simply Wall St.

6 months ago

Exploring XD And Two Other High Growth Tech Stocks In Asia

AAPG

MT Newswires

6 months ago

Sector Update: Health Care Stocks Flat to Higher Premarket Thursday

AAPG

MT Newswires

6 months ago

Ascentage Pharma Group's 2024 Loss Narrows, Revenue Rises

Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates
AAPG

GlobeNewswire

6 months ago

Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates

Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025
AAPG

GlobeNewswire

6 months ago

Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025

Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
AAPG

GlobeNewswire

7 months ago

Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025

Ascentage Secures Third Breakthrough Therapy for Ph+ ALL Treatment
AAPG

Exec Edge

7 months ago

Ascentage Secures Third Breakthrough Therapy for Ph+ ALL Treatment

AAPG

MT Newswires

7 months ago

Ascentage Pharma's Olverembatinib Granted Breakthrough Therapy Designation in China

AAPG

GlobeNewswire

7 months ago

Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

AAPG

MT Newswires

8 months ago

Sector Update: Health Care Stocks Lower Friday Afternoon

AAPG

MT Newswires

8 months ago

Ascentage Pharma Says Underwriters Exercise Option to Buy Additional American Depositary Shares

AAPG

GlobeNewswire

8 months ago

Ascentage Pharma Announces Partial Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares

AAPG

MT Newswires

8 months ago

Ascentage Pharma Closes IPO of 7.33 Million American Depositary Shares

AAPG

GlobeNewswire

8 months ago

Ascentage Pharma Announces Closing of U.S. Initial Public Offering

Share on Social Networks: